Alvotech And JAMP Partner On Canadian Biosimilars

Partnership Covers Five Alvotech Biosimilar Candidates

 
• By Akriti Seth

Alvotech and JAMP Pharma have struck a partnership deal to market five biosimilars in Canada that have a combined current branded market value of more than $2bn annually.

Canada_Map_Globe
Alvotech and JAMP Pharma are aiming to bring five biosimilars to the Canadian market • Source: Shutterstock

More from Deals

More from Business